Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02566577 · ClinicalTrials.gov registry record · Phase 4

Physiologic Effects of RBC Transfusion

A Phase 4 study, sponsored by Emory University.

Terminated
Registry status
Phase 4
Development phase
15
Enrollment target

NCT02566577: Clinical Trial Phase 4 study, sponsored by Emory University.

NCT02566577 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02566577, a Phase 4 study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
Phase 4
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to determine how red blood cell transfusions, particularly the length of storage time of units of packed red blood cells, affects the cardiovascular function in patients receiving transfusions. This study will also determine the most ideal way of storing and processing blood, and assess how transfusion affects a person's ability to exercise and how their blood vessels relax and contract.

Primary Outcome

Brachial artery flow-mediated dilation (FMD) will be performed by using ultrasonography. The brachial artery of the non-dominant arm will be imaged using a high-resolution 13 MHz ultrasound transducer. A blood pressure cuff on the forearm will be inflated to supra-systolic pressures to produce 5 minutes of ischemia. After cuff deflation, imaging of the brachial artery will be performed continuously for the next 120 seconds and the flow-mediated dilation will be calculated. Change in FMD is the p

Interventions

  • BIOLOGICAL Fresh red blood cell (RBC) transfusion
  • BIOLOGICAL Storage-aged red blood cell (RBC) transfusion
  • DEVICE Electronic infusion pump

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2013-07
Est. Completion 2018-03
Phase Phase 4
Emory University

1,208 total trials

Why NCT02566577 stopped before completion

NCT02566577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Fresh red blood cell (RBC) transfusion is the first listed.

NCT02566577 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02566577 about?

NCT02566577 is a clinical study titled "Physiologic Effects of RBC Transfusion". The purpose of this study is to determine how red blood cell transfusions, particularly the length of storage time of units of packed red blood cells, affects the cardiovascular function in patients receiving transfusions. This study will also determine the most ideal way of storing and processing b...

What is the current status of trial NCT02566577?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2013-07. Estimated completion is 2018-03.

What interventions are being tested in trial NCT02566577?

The interventions under investigation include: Fresh red blood cell (RBC) transfusion (BIOLOGICAL), Storage-aged red blood cell (RBC) transfusion (BIOLOGICAL), Electronic infusion pump (DEVICE).

Who is sponsoring clinical trial NCT02566577?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02566577's enrollment target sits among peer trials

15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02566577, the US trial registry maintained by the National Library of Medicine. NCT02566577 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.